NORTHERN TRUST CORP - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 24 filers reported holding CANDEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,048
-27.0%
19,6170.0%0.00%
Q2 2023$24,717
-6.7%
19,6170.0%0.00%
Q1 2023$26,483
+2.2%
19,617
+35.4%
0.00%
Q4 2022$25,925
-42.4%
14,4830.0%0.00%
Q3 2022$45,000
-4.3%
14,4830.0%0.00%
Q2 2022$47,000
-30.9%
14,483
+7.6%
0.00%
Q1 2022$68,000
-35.2%
13,4550.0%0.00%
Q4 2021$105,00013,4550.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$9,850,0005.31%
Sands Capital Ventures, LLC 811,737$4,132,0000.86%
Empirical Asset Management, LLC 12,000$61,0000.06%
683 Capital Management, LLC 40,929$208,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$382,0000.01%
FRANKLIN RESOURCES INC 1,125,000$5,726,0000.00%
Kestra Advisory Services, LLC 12,500$64,0000.00%
FMR LLC 1,972,226$10,039,0000.00%
High Net Worth Advisory Group LLC 300$2,0000.00%
NORTHERN TRUST CORP 13,455$68,0000.00%
View complete list of CANDEL THERAPEUTICS INC shareholders